Search results for "Urinary tract infections"
Study analyzes diagnostic errors in primary care
Diagnostic errors in primary care are often related to process breakdowns during the clinical encounter, according to a new study.
https://immattersacp.org/weekly/archives/2013/03/05/4.htm
5 Mar 2013
Rare but resistant and deadly strains of Enterobacteriaceae increasing
Rare but deadly strains of carbapenem-resistant Enterobacteriaceae (CRE) are on the rise, stated a report.
https://immattersacp.org/weekly/archives/2013/03/12/5.htm
12 Mar 2013
Zolpidem dose for women lowered, diabetes drug approved
This regulatory update covers warnings to lower zolpidem doses in women and approvals for a new drug to improve blood glucose control in adults with type 2 diabetes.
https://immattersacp.org/archives/2013/04/fda.htm
1 Apr 2013
Daily antibiotics appeared most effective for recurrent UTIs
Daily antibiotics appeared to be the most effective strategy for combating recurrent urinary tract infections (UTIs), according to a new analysis.
https://immattersacp.org/weekly/archives/2013/10/01/2.htm
1 Oct 2013
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
CDC reports new data on hospital-acquired infections
The CDC released 2 different reports on hospital-acquired infection (HAI) rates in the U.S. last week.
https://immattersacp.org/weekly/archives/2014/04/01/5.htm
1 Apr 2014
Doripenem not for pneumonia; migraine device approved
This update covers a labeling change for doripenem (Doribax) and a warning about risk of death for ventilator patients with pneumonia, among other regulatory actions.
https://immattersacp.org/archives/2014/05/fda.htm
1 May 2014
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Virtual visits pose real issues for physicians
There could be 1 million virtual health consultations done by phone or video by the end of 2014, with growth expected in 2015. Observers are weighing the benefits of access against the potential lack of an ongoing doctor-patient relationship.
https://immattersacp.org/archives/2014/11/virtual-visit.htm
1 Nov 2014
Urinary incontinence is overlooked but treatable
This issue covers topics including urinary incontinence, the new drug class of SGLT2 inhibitors for diabetes, and more on the principles of diabetes care.
https://immattersacp.org/archives/2015/02/editors.htm
1 Feb 2015